I agree that this site is using cookies. You can find further informations here.
X
Hupperts, Raymond
357  results:
Search for persons X
?
1

Hallmarks of spinal cord pathology in multiple sclerosis:

Kreiter, Daniel ; Postma, Alida A. ; Hupperts, Raymond.
Journal of the Neurological Sciences.  456 (2024)  - p. 122846 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Time to Qualifying Relapse by Previous Disease-Modifying Th..:

Patti, Francesco ; Brochet, Bruno ; Havrdová, Eva Kubala...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105331 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Improvements in Quality of Life Over 2 Years in Patients Tr..:

Solari, Alessandra ; Montalban, Xavier ; Lechner-Scott, Jeannette...
Multiple Sclerosis and Related Disorders.  71 (2023)  - p. 104356 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Improvements in quality of life over 2 years with cladribin..:

Brochet, Bruno ; Solari, Alessandra ; Lechner-Scott, Jeannette...
Multiple Sclerosis Journal.  29 (2023)  14 - p. 1808-1818 , 2023
Link: https://doi.org/10.1177/..
 
?
5

Effect of disease-modifying treatment on spinal cord lesion..:

Kreiter, Daniel ; Spee, Romy ; Merry, Audrey..
Multiple Sclerosis and Related Disorders.  79 (2023)  - p. 104994 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Efficacy of prolonged-release fampridine versus placebo on ..:

Hupperts, Raymond ; Gasperini, Claudio ; Lycke, Jan...
Therapeutic Advances in Neurological Disorders.  15 (2022)  - p. 175628642210903 , 2022
Link: https://doi.org/10.1177/..
 
?
7

Smouldering multiple sclerosis: the 'real MS':

Giovannoni, Gavin ; Popescu, Veronica ; Wuerfel, Jens...
Therapeutic Advances in Neurological Disorders.  15 (2022)  - p. 175628642110667 , 2022
Link: https://doi.org/10.1177/..
 
?
8

Treatment satisfaction, safety, and tolerability of cladrib..:

Brochet, Bruno ; Hupperts, Raymond ; Langdon, Dawn...
Multiple Sclerosis and Related Disorders.  57 (2022)  - p. 103385 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Improvements in Quality of Life at 1 Year in Patients Treat..:

Solari, Alessandra ; Montalban, Xavier ; Lechner-Scott, Jeannette...
Multiple Sclerosis and Related Disorders.  59 (2022)  - p. 103623 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Treatment Response Score to Glatiramer Acetate or Interfero..:

Bovis, Francesca ; Kalincik, Tomas ; Lublin, Fred...
Neurology.  96 (2021)  2 - p. , 2021
Link: https://doi.org/10.1212/..
 
?
11

Effect of Disease-Modifying Therapy on Disability in Relaps..:

Kalincik, Tomas ; Diouf, Ibrahima ; Sharmin, Sifat...
Neurology.  96 (2021)  5 - p. , 2021
Link: https://doi.org/10.1212/..
 
?
12

Vitamin D supplementation in multiple sclerosis: an expert ..:

Boltjes, Robin ; Knippenberg, Stephanie ; Gerlach, Oliver..
Expert Review of Neurotherapeutics.  21 (2021)  6 - p. 715-725 , 2021
Link: https://doi.org/10.1080/..
 
?
13

NK/T cell ratios associate with interleukin-2 receptor alph..:

Mimpen, Max ; Rolf, Linda ; Muris, Anne-Hilde...
Journal of Neuroimmunology.  353 (2021)  - p. 577499 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Vitamin D related genetic polymorphisms affect serological ..:

Mimpen, Max ; Rolf, Linda ; Poelmans, Geert...
PLOS ONE.  16 (2021)  12 - p. e0261097 , 2021
Link: https://doi.org/10.1371/..
 
?
15

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L. ; Zhang, Yuanhui...
PharmacoEconomics.  40 (2021)  3 - p. 323-339 , 2021
Link: https://doi.org/10.1007/..
 
1-15